SCHEMBL18353754

SCHEMBL18353754

C=CC(=O)OCCOc1ccc(C(c2ccc(-c3nc4ccccc4s3)cc2)(c2ccc3ccccc3c2)c2ccc3cc(OCCOC(=O)C=C)ccc3c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.44
RXFP1 Q9HBX9 4/20 0.44
THRB P10828 2/20 0.43
ATP4A P20648 4/20 0.43
ATP4B P51164 4/20 0.43
TP53 P04637 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
KMT2A Q03164 2/20 0.42
KDM4E B2RXH2 2/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
TNF P01375 1/20 0.42
NOD1 Q9Y239 1/20 0.42
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18353246 0.88 THRB (0.49) MAPTRXFP1THRBATP4AATP4B
SCHEMBL25713737 0.85 THRB (0.46) MAPTRXFP1THRBATP4AATP4B
SCHEMBL18353802 0.79 MAPT (0.37) MAPTRXFP1THRBATP4AATP4B
SCHEMBL18353100 0.78 MAPT (0.38) MAPTRXFP1THRBATP4AATP4B
SCHEMBL25713588 0.78 THRB (0.49) MAPTRXFP1THRBATP4AATP4B
SCHEMBL18353245 0.78 MAPT (0.37) MAPTRXFP1THRBATP4AATP4B
SCHEMBL18353819 0.77 MAPT (0.40) MAPTRXFP1THRBATP4AATP4B
SCHEMBL12545487 0.76 RAB9A (0.59) MAPTTP53SMN1; SMN2KMT2AKDM4E
SCHEMBL30095996 0.75 THRB (0.69) MAPTTHRBTP53SMN1; SMN2KMT2A
SCHEMBL69160 0.75 THRB (0.69) MAPTTHRBTP53SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9902794-B2 Curable composition, optical component and compound FUJIFILM CORPORATION (JP) 2018-02-27 US disclosed
US-9902794-B2 Curable composition, optical component and compound FUJIFILM CORPORATION (JP) 2018-02-27 US disclosed
US-20170002124-A1 CURABLE COMPOSITION, OPTICAL COMPONENT AND COMPOUND FUJIFILM CORPORATION (JP) 2017-01-05 US disclosed
US-20170002124-A1 CURABLE COMPOSITION, OPTICAL COMPONENT AND COMPOUND FUJIFILM CORPORATION (JP) 2017-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170002124-A1 CURABLE COMPOSITION, OPTICAL COMPONENT AND COMPOUND CCNT1, ARPC4, NLRP1 MAPT 183/4885RXFP1 32/4885THRB 4156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.